COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

IRG Summary

The scientific areas are broad and include: bioengineering, biochemistry, biophysics, cancer biology, cell biology, chemistry, molecular biology, and genetics. IMST reviews most of the fellowship applications (F30, F31, F32, F33, etc.) and small business (SBIR/STTR) grant applications (R41, R42, R43, R44, etc.) that have a scientific/technological focus appropriate for one of the current molecular science IRGs, specifically Biological Chemistry and Macromolecular Biophysics (BCMB), Bioengineering Sciences & Technologies (BST), Cell Biology (CB), Genes, Genomes & Genetics (GGG), and Oncology 1 – Basic & Translational (OBT). Research grant applications (R01, R03, R15, R21, etc.) focused on enabling tools and technologies, as well as a significant portion of other crosscutting applications (P01, P41, S10, etc.) are also reviewed in IMST.